ArticleJournal of rheumatic diseases2021

Health-related Quality of Life Outcomes of Adalimumab for Patients With Rheumatoid Arthritis in Korea.

Myeung-Su Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.